Published in AIDS Res Ther on June 21, 2008
HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. PLoS One (2011) 1.45
Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural Tanzania. AIDS Res Hum Retroviruses (2013) 0.97
Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1. Clin Infect Dis (2009) 0.97
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon. J Med Virol (2010) 0.94
Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique. PLoS One (2013) 0.82
HIV-1 drug resistance in recently HIV-infected pregnant mother's naïve to antiretroviral therapy in Dodoma urban, Tanzania. BMC Infect Dis (2013) 0.80
HIV-1 pol diversity among female bar and hotel workers in Northern Tanzania. PLoS One (2014) 0.77
HIV-1 drug mutations in children from northern Tanzania. J Antimicrob Chemother (2014) 0.77
Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010. AIDS Res Treat (2012) 0.76
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med (2007) 6.65
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS (2006) 5.31
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis (2007) 3.46
Global epidemiology of HIV. J Med Virol (2006) 2.28
Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70
Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS (2003) 1.61
Surveillance of HIV and syphilis infections among antenatal clinic attendees in Tanzania-2003/2004. BMC Public Health (2006) 1.47
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS (2006) 1.40
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS (2005) 1.16
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme. J Med Virol (2005) 1.10
Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance. AIDS (2000) 1.10
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. AIDS Res Hum Retroviruses (2003) 1.10
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. J Clin Virol (2006) 1.03
Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients. FEMS Immunol Med Microbiol (2006) 0.97
HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania. AIDS Res Hum Retroviruses (2003) 0.97
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Hum Retroviruses (2008) 0.94
Resistance to antiretroviral therapy among patients in Uganda. J Acquir Immune Defic Syndr (2001) 0.91
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda. AIDS Res Hum Retroviruses (2007) 0.90
Identification of CRF10_CD viruses among bar and hotel workers in Moshi, Northern Tanzania. AIDS Res Hum Retroviruses (2005) 0.85
Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis (2005) 4.41
Assessing immunization data quality from routine reports in Mozambique. BMC Public Health (2005) 3.05
Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol (2002) 2.92
Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health (2008) 2.36
Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis (2006) 2.07
Pastoralism and delay in diagnosis of TB in Ethiopia. BMC Public Health (2009) 1.81
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis (2003) 1.78
Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study. BMC Public Health (2008) 1.66
Health care seeking among pulmonary tuberculosis suspects and patients in rural Ethiopia: a community-based study. BMC Public Health (2009) 1.60
Knowledge and perception of pulmonary tuberculosis in pastoral communities in the middle and Lower Awash Valley of Afar region, Ethiopia. BMC Public Health (2010) 1.57
Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health (2005) 1.57
Diagnostic and treatment delay among Tuberculosis patients in Afar Region, Ethiopia: a cross-sectional study. BMC Public Health (2012) 1.48
Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol (2004) 1.36
Prevalence of gonococcal and chlamydial infections and sexual risk behavior among youth in Addis Ababa, Ethiopia. Sex Transm Dis (2002) 1.33
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation (2002) 1.32
Mycobacterium tuberculosis mammalian cell entry operon (mce) homologs in Mycobacterium other than tuberculosis (MOTT). FEMS Immunol Med Microbiol (2002) 1.26
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I. J Immunol (2003) 1.25
Do Malawian women critically assess the quality of care? A qualitative study on women's perceptions of perinatal care at a district hospital in Malawi. Reprod Health (2012) 1.24
Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients. Scand J Infect Dis (2002) 1.22
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.21
Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis (2002) 1.19
Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. BMC Infect Dis (2006) 1.15
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis (2004) 1.11
HIV genetic diversity in Cameroon: possible public health importance. AIDS Res Hum Retroviruses (2006) 1.11
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res (2003) 1.10
Expression of the mceA, esat-6 and hspX genes in Mycobacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply. Microbiology (2002) 1.10
Why some women fail to give birth at health facilities: a qualitative study of women's perceptions of perinatal care from rural Southern Malawi. Reprod Health (2013) 1.10
Immunization coverage in Mozambique: from concepts to decision-making. Health Policy (2006) 1.08
[Re: Hearing loss in children in Östfold county 2000-09]. Tidsskr Nor Laegeforen (2015) 1.08
Predicting non-coding RNA genes in Escherichia coli with boosted genetic programming. Nucleic Acids Res (2005) 1.07
Transport of ticks by migratory passerine birds to Norway. J Parasitol (2009) 1.03
Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia. APMIS (2012) 1.03
Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia. BMC Infect Dis (2014) 1.02
Reproductive health perceptions, beliefs and sexual risk-taking among youth in Addis Ababa, Ethiopia. Patient Educ Couns (2003) 1.01
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res (2004) 1.00
A new approach to global health institutions? A case study of new vaccine introduction and the formation of the GAVI Alliance. Soc Sci Med (2010) 1.00
Abnormal interleukin-7 function in common variable immunodeficiency. Blood (2004) 0.99
Trends in HIV-1 prevalence and risk behaviours over 15 years in a rural population in Kilimanjaro region of Tanzania. AIDS Res Ther (2007) 0.99
Epidemic of tuberculosis in the former Soviet Union: social and biological reasons. Tuberculosis (Edinb) (2005) 0.98
Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test. BMC Infect Dis (2011) 0.97
Leptotrichia amnionii, an emerging pathogen of the female urogenital tract. J Clin Microbiol (2007) 0.96
Assessment of knowledge and practice of private practitioners regarding tuberculosis control in Ethiopia. J Infect Dev Ctries (2012) 0.95
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Hum Retroviruses (2008) 0.94
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants. J Infect Dis (2003) 0.94
Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia. BMC Infect Dis (2010) 0.93
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant (2005) 0.92
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood (2005) 0.91
Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital. J Clin Microbiol (2012) 0.89
Human cytomegalovirus infection increases mitochondrial biogenesis. Mitochondrion (2011) 0.88
Clonal reconquest of antibiotic-susceptible Salmonella enterica serotype Typhi in Son La Province, Vietnam. Am J Trop Med Hyg (2007) 0.88
The role of properdin in zymosan- and Escherichia coli-induced complement activation. J Immunol (2012) 0.87
Knowledge of cervical tuberculosis lymphadenitis and its treatment in pastoral communities of the Afar region, Ethiopia. BMC Public Health (2011) 0.87
Assessment of measles immunity among infants in Maputo City, Mozambique. BMC Public Health (2008) 0.87
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes. FASEB J (2002) 0.86
Pathology of camel tuberculosis and molecular characterization of its causative agents in pastoral regions of Ethiopia. PLoS One (2011) 0.86
Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting. Virol J (2010) 0.86
New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev (2005) 0.84
Tiling array analysis of UV treated Escherichia coli predicts novel differentially expressed small peptides. PLoS One (2010) 0.83
Spoligotyping of Mycobacterium tuberculosis isolates among pulmonary tuberculosis patients in Amhara Region, Ethiopia. APMIS (2013) 0.82
Tuberculosis in Goats and Sheep in Afar Pastoral Region of Ethiopia and Isolation of Mycobacterium tuberculosis from Goat. Vet Med Int (2012) 0.81
Heterogeneity of Mycobacterium tuberculosis isolates in Sunamganj District, Bangladesh. Scand J Infect Dis (2006) 0.81
Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh. Scand J Infect Dis (2007) 0.79
Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties. Arterioscler Thromb Vasc Biol (2006) 0.78
Evolution of human immunodeficiency virus type 1 serotypes in northern Tanzania: a retrospective study. APMIS (2008) 0.77
Tuberculosis management time: an alternative parameter for measuring the tuberculosis infectious pool. Trop Med Int Health (2014) 0.77
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis. BMC Infect Dis (2012) 0.77
Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment. Stat Med (2012) 0.76
Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro. Med Mycol (2010) 0.76
Some problems related to risk-benefit assessments in clinical testing of new vaccines. IRB (1993) 0.75
Problems related to informed consent from young teenagers participating in efficacy testing of a new vaccine. IRB (1993) 0.75
[Tuberculosis vaccines]. Tidsskr Nor Laegeforen (2006) 0.75
Recurrent group A Streptococcal genital infection after Puerperal sepsis. Scand J Infect Dis (2003) 0.75
[Community-acquired pneumonia--management in hospitals]. Tidsskr Nor Laegeforen (2003) 0.75
The politics of global immunization initiatives: can we learn from research on global environmental issues? Health Policy (2007) 0.75
Tidsskr Nor Laegeforen (2020) 0.75
Tiling array study of MNNG treated Escherichia coli reveals a widespread transcriptional response. Sci Rep (2013) 0.75